MetaVia Inc.
General ticker "MTVA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $15.7M (TTM average)
MetaVia Inc. does not follow the US Stock Market performance with the rate: -24.5%.
Estimated limits based on current volatility of 4.2%: low 1.58$, high 1.71$
Factors to consider:
- Total employees count: 8 (-11.1%) as of 2025
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Need for additional capital, Regulatory and compliance, Clinical trial failure, Acquisition/divestiture risks, Intellectual property risks
- Current price 67.4% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.10$, 15.44$]
- 2026-12-31 to 2027-12-31 estimated range: [4.05$, 12.59$]
Short-term MTVA quotes
Long-term MTVA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $15.89MM | $28.81MM | $13.71MM |
| Operating Income | $-15.89MM | $-28.81MM | $-13.71MM |
| Non-Operating Income | $3.42MM | $1.22MM | $0.73MM |
| R&D Expense | $9.16MM | $21.55MM | $6.80MM |
| Income(Loss) | $-12.47MM | $-27.59MM | $-12.97MM |
| Net Income(Loss)* | $-12.47MM | $-27.59MM | $-12.97MM |
| Stockholders Equity | $16.68MM | $7.93MM | $5.33MM |
| Assets | $22.78MM | $16.26MM | $11.12MM |
| Operating Cash Flow | $-10.80MM | $-24.71MM | $-15.70MM |
| Capital expenditure | $0.05MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $-0.05MM | $-0.01MM | $-0.00MM |
| Financing Cash Flow | $-0.08MM | $18.30MM | $9.96MM |
| Earnings Per Share** | $-27.05 | $-39.13 | $-7.35 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.